Vaxcyte, Inc. (PCVX) income statement
PCVXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$58.52−0.88 (-1.48%)
Close on Nov 18, 2026Market cap $8.71BP/E –Yield 0.00%
Vaxcyte, Inc. financial ratios
See a number that looks wrong?